CN105902970A - Chuanxiong rhizome-containing traditional Chinese medicine composition for preventing and treating radiation - Google Patents

Chuanxiong rhizome-containing traditional Chinese medicine composition for preventing and treating radiation Download PDF

Info

Publication number
CN105902970A
CN105902970A CN201610487405.1A CN201610487405A CN105902970A CN 105902970 A CN105902970 A CN 105902970A CN 201610487405 A CN201610487405 A CN 201610487405A CN 105902970 A CN105902970 A CN 105902970A
Authority
CN
China
Prior art keywords
chinese medicine
medicine composition
parts
raw material
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610487405.1A
Other languages
Chinese (zh)
Inventor
李翠锦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201610487405.1A priority Critical patent/CN105902970A/en
Publication of CN105902970A publication Critical patent/CN105902970A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9066Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236Ligusticum (licorice-root)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a chuanxiong rhizome-containing traditional Chinese medicine composition which can effectively solve the problem of low immunity caused by long-term radiation so as to reduce radiation hazards. The traditional Chinese medicine composition provided by the invention is prepared from the following components as raw materials: 25-35 parts of chuanxiong rhizome, 10-20 parts of angelica, 10-15 parts of astragalus root, 8-12 parts of rhizoma zedoariae, 5-10 parts of fructus psoraleae and 1-5 parts of ginkgo leaves. A preparation method of the traditional Chinese medicine composition comprises the following steps: chipping and mixing the medicinal raw materials; decocting the mixture with 70-85% ethanol; filtering the decoction liquid; and carrying out vacuum concentration to obtain viscous paste, namely the traditional Chinese medicine composition.

Description

A kind of Chinese medicine composition of the preventing and treating radiation containing Rhizoma Chuanxiong
Technical field
The present invention relates to compositions, a kind of Chinese medicine composition preventing and treating radiation.
Background technology
Along with development and the extensive application of radiotherapy clinically of nuclear technology, particularly at medical domain, radiodiagnosis Non-with treatment use extensively clinically, tumor patient being carried out radiotherapy and has become as the conventional means of oncotherapy, these all increase Add the probability of medical personnel and radiation contacts.Radiation damage how is prevented to be increasingly subject to the attention of people.People start to amass Pole is explored and is effectively radiated protective agents.
Long-term raying is irradiated, and human body can be made to produce discomfort, serious caused human organ and the damage of system, cause The generation of various diseases, such as: leukemia, aplastic anemia, various tumor, retinopathy, reproductive system disease, senilism Deng;Tradition Anti-Radiation Countermeasures mainly installs radiation prevention film additional on electrical equipment, or wears anti-radiation clothes etc..Due to more known tools The chemicals toxicity having radiation resistance is relatively big, and the radioprotective Chinese medicine that therefore research toxic and side effects is little seems the most necessary.Specially Profit CN 201410022608.4 discloses a kind of compositions with Radix Pseudostellariae, Fructus Psoraleae, Fructus Lycii, Herba Dendrobii etc. as component to be had Good radiation resistance, patent CN201510455861.3 discloses a kind of alimentation composition reducing radiation hazradial bundle, has Certain radiation resistance.
Summary of the invention
For above-mentioned situation, the present invention provides a kind of Chinese medicine composition preventing and treating radiation, by the collaborative work of different Chinese medicines With, improve immunity, for alleviating or reduce the long-term harm accepting radiation.
The present invention adopts the following technical scheme that, this Chinese medicine composition, makes with following component for raw material: Rhizoma Chuanxiong, Radix Angelicae Sinensis, Huang Stilbene, Rhizoma Curcumae, Fructus Psoraleae, Folium Ginkgo, by above-mentioned medicinal raw material chopping, mix, decoct with ethanol water, decoction liquor Filter, concentrating under reduced pressure, obtain the mastic of thickness, obtain described Chinese medicine composition.
Further, preferably, the Chinese medicine composition that the present invention provides, make with following component for raw material: river Rhizome of chuanxiong 25-35 part, Radix Angelicae Sinensis 10-20 part, Radix Astragali 10-15 part, Rhizoma Curcumae 8-12 part, Fructus Psoraleae 5-10 part, Folium Ginkgo 1-5 part.By above-mentioned Medicinal raw material chopping, mix, decoct with the ethanol of 70-85%, decoction liquor filters, and concentrating under reduced pressure obtains the cream of thickness Body, obtains described Chinese medicine composition.
Further preferably with Rhizoma Chuanxiong 25-30 part, Radix Angelicae Sinensis 15-18 part, Radix Astragali 10-15 part, Rhizoma Curcumae 10-12 part, Fructus Psoraleae 5-8 Part, Folium Ginkgo 3-5 part are as raw material;
More preferably using Rhizoma Chuanxiong 27 parts, Radix Angelicae Sinensis 16 parts, the Radix Astragali 12 parts, Rhizoma Curcumae 10 parts, Fructus Psoraleae 5 parts, Folium Ginkgo 3 parts as raw material.
Further, ethanol water volumetric usage is 6-10 times of raw medicinal material weight, preferred alcohol aqueous solution volume Consumption is 8 times of raw medicinal material weight.
Detailed description of the invention
For the object, technical solutions and advantages of the present invention are better described, below in conjunction with specific embodiment to the present invention It is described further.
Embodiment 1
Rhizoma Chuanxiong 27 parts, Radix Angelicae Sinensis 16 parts, the Radix Astragali 12 parts, Rhizoma Curcumae 10 parts, Fructus Psoraleae 5 parts, Folium Ginkgo 3 parts;By above-mentioned raw medicinal material Chopping, mixes, and the ethanol with 80% decocts, decoction liquor filtration, concentrating under reduced pressure obtains the mastic of thickness, and wherein 80% Ethanol volumetric usage is 8 times of medicinal raw material weight.
Embodiment 2
Rhizoma Chuanxiong 25 parts, Radix Angelicae Sinensis 20 parts, the Radix Astragali 10 parts, Rhizoma Curcumae 12 parts, Fructus Psoraleae 10 parts, Folium Ginkgo 5 parts;By above-mentioned raw medicinal material Chopping, mixes, and the ethanol with 85% decocts, decoction liquor filtration, concentrating under reduced pressure obtains the mastic of thickness, and wherein 85% Ethanol volumetric usage is 6 times of medicinal raw material weight.
Embodiment 3
Rhizoma Chuanxiong 35 parts, Radix Angelicae Sinensis 10 parts, the Radix Astragali 15 parts, Rhizoma Curcumae 8 parts, Fructus Psoraleae 8 parts, Folium Ginkgo 1 part.Above-mentioned medicinal raw material is cut Broken, mix, the ethanol with 70% decocts, and decoction liquor filters, and concentrating under reduced pressure obtains the mastic of thickness, the wherein second of 70% Alcohol volumetric usage is 8 times of medicinal raw material weight.
Embodiment 4
Rhizoma Chuanxiong 31 parts, Radix Angelicae Sinensis 17 parts, the Radix Astragali 12 parts, Rhizoma Curcumae 10 parts, Fructus Psoraleae 7 parts, Folium Ginkgo 3 parts.By above-mentioned medicinal raw material Chopping, mixes, and the ethanol with 75% decocts, and decoction liquor filters, and concentrating under reduced pressure obtains the mastic of thickness, obtains described Chinese medicine composition.Wherein ethanol volumetric usage is medicinal raw material weight 10 times of 75%.
1, Antiradiation injury experiment:
With mice as object of study, investigate the Chinese medicine composition of the embodiment of the present invention 1 to 30 days survival rates of raying mice Affecting, the human body of the Chinese medicine composition of the present invention recommends consumption to be 6g/60kg.BW every day, and following basic, normal, high dosage group is suitable In 1 times, 5 times, 10 times of human body recommended dose, and test as follows:
(1) selecting SD mice, female 75, weight range is 20-22g.Raise one week in the case of feeding environment is identical;
(2) being randomly divided into 5 groups, often group 15, is divided into normal group, model control group, low dose group, middle dosage group, high dose group; Normal group refuses any process, and model group gives distilled water, and basic, normal, high dosage component does not give the embodiment 1 of corresponding dosage Chinese medicine composition, uses the mode of gavage (ig), every day 1 time, continuous gavage 30d;
5h after (3) the 30th days gavages, in addition to normal group, remaining 4 groups all carry out whole body disposable 60Co gamma-rays irradiate, irradiate away from From for 1.0m, exposure dose is 8.5Gy;After irradiation, observed and recorded respectively organizes the survival state of mice, body weight change, calculates each group little The mean survival time of Mus, 30d survival rate etc..
The Chinese medicine composition of the present invention is as shown in table 1 to the result (x ± s) of 30 days survival rates of raying mice.
Table 1
As it can be seen from table 1 when give the Chinese medicine composition of the present invention with low middle high dose, it is the poorest that it has with matched group Different, it is seen then that the Chinese medicine composition of the present invention can significantly improve the survival rate by 8.5Gy roentgenization mice 30d, extend by spoke Penetrate the life span of mice.Therefore, the Chinese medicine composition of the present invention has the effect of pre-radioprotective.
2, the impact on spleen
Spleen is maximum lymphatic organ, is also one of important peripheral immune organ, containing substantial amounts of T cell, NKT Cell and Tumor-infiltrating lymphocytes etc..Spleen is also the place that haematogenous antigen produces immunne response, can synthesize And secrete such as the bioactive substance such as complement, IFN, spleen weight reflects the immune state of body indirectly.Research display, irradiates comparison Group mice spleen heavily significantly reduces, and gives the present invention Chinese medicine composition of high, medium and low dosage, significantly increases mice after irradiation Spleen weight, the present invention is high, middle, and dosage group compares with irradiation control group, has significant difference.Result is as shown in table 2:
The impact on spleen of table 2 Chinese medicine composition of the present invention
Above experimental result shows indirectly, and the Chinese medicine composition of the present invention can improve body immunity, thus prevents and treats radiation, fall Low emissivity endangers.
The foregoing is only the optimal case study on implementation of the present invention, be merely illustrative for the purpose of the present invention, and unrestricted Property.Those skilled in the art understands, it can be carried out some and revise in the scope of the claims in the present invention, but all To fall within the scope of protection of the present invention.

Claims (6)

1. the Chinese medicine composition of the preventing and treating radiation containing Rhizoma Chuanxiong, it is characterised in that described Chinese medicine composition is adopted with the following method Preparation: with Rhizoma Chuanxiong, Radix Angelicae Sinensis, the Radix Astragali, Rhizoma Curcumae, Fructus Psoraleae, Folium Ginkgo as raw material, shreds raw material, mixes, use ethanol water Solution decocts, and decoction liquor filters, and concentrating under reduced pressure obtains the mastic of thickness, obtains described Chinese medicine composition.
Chinese medicine composition the most according to claim 1, it is characterised in that the consumption of each raw material is: Rhizoma Chuanxiong 25-35 part, Radix Angelicae Sinensis 10-20 part, Radix Astragali 10-15 part, Rhizoma Curcumae 8-12 part, Fructus Psoraleae 5-10 part, Folium Ginkgo 1-5 part.
3. according to the Chinese medicine composition described in claim 1-2, it is characterised in that the consumption of each raw material is: Rhizoma Chuanxiong 25-30 part, when Return 15-18 part, Radix Astragali 10-15 part, Rhizoma Curcumae 10-12 part, Fructus Psoraleae 5-8 part, Folium Ginkgo 3-5 part.
4. according to the Chinese medicine composition described in claim 1-3, it is characterised in that the consumption of each raw material is: Rhizoma Chuanxiong 27 parts, Radix Angelicae Sinensis 16 parts, the Radix Astragali 12 parts, Rhizoma Curcumae 10 parts, Fructus Psoraleae 5 parts, Folium Ginkgo 3 parts.
5. according to the Chinese medicine composition described in claim 1-4, it is characterised in that described ethanol water is 70-85% ethanol, second Alcohol-water solution volumetric usage is 6-10 times of raw medicinal material weight.
6. according to the Chinese medicine composition described in claim 1-5, it is characterised in that ethanol water volumetric usage is raw material weight 8 times.
CN201610487405.1A 2016-06-29 2016-06-29 Chuanxiong rhizome-containing traditional Chinese medicine composition for preventing and treating radiation Pending CN105902970A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610487405.1A CN105902970A (en) 2016-06-29 2016-06-29 Chuanxiong rhizome-containing traditional Chinese medicine composition for preventing and treating radiation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610487405.1A CN105902970A (en) 2016-06-29 2016-06-29 Chuanxiong rhizome-containing traditional Chinese medicine composition for preventing and treating radiation

Publications (1)

Publication Number Publication Date
CN105902970A true CN105902970A (en) 2016-08-31

Family

ID=56758981

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610487405.1A Pending CN105902970A (en) 2016-06-29 2016-06-29 Chuanxiong rhizome-containing traditional Chinese medicine composition for preventing and treating radiation

Country Status (1)

Country Link
CN (1) CN105902970A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1160560A (en) * 1996-03-21 1997-10-01 廖柏松 Chinese patent drug for curing leukopenia and its preparation process
CN102389511A (en) * 2011-11-22 2012-03-28 中国人民解放军第三军医大学第二附属医院 Anti-radiation Chinese medicine preparation and preparation method thereof
CN104840722A (en) * 2015-05-27 2015-08-19 苏笮斌 Functional health-preserving treasure composition as well as preparation method and application method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1160560A (en) * 1996-03-21 1997-10-01 廖柏松 Chinese patent drug for curing leukopenia and its preparation process
CN102389511A (en) * 2011-11-22 2012-03-28 中国人民解放军第三军医大学第二附属医院 Anti-radiation Chinese medicine preparation and preparation method thereof
CN104840722A (en) * 2015-05-27 2015-08-19 苏笮斌 Functional health-preserving treasure composition as well as preparation method and application method thereof

Similar Documents

Publication Publication Date Title
CN102423421B (en) Medicine for treating hypertension
CN102018937B (en) Medicament for treating acne and preparation method thereof
CN103751497A (en) Medicament for treating mastitis and preparation method thereof
CN104758229A (en) Pure natural acne-removing facial mask
CN105078825A (en) Traditional Chinese medicine mask for whitening skin and preparation method thereof
CN102935133B (en) Traditional Chinese medicine composition for treating rheumatic arthritis as well as preparation method and application thereof
CN102205021A (en) Collateral-moistering bone-penetrating oil
CN103446376A (en) Traditional Chinese medicine composition used for treating radiation proctitis
CN1546158A (en) Specific medicine for treating cancer and preparing process
CN107854565B (en) Anti-radiation traditional Chinese medicine composition
CN105902970A (en) Chuanxiong rhizome-containing traditional Chinese medicine composition for preventing and treating radiation
CN104306846A (en) Traditional Chinese medicine for treating attention deficit hyperactivity disorder
CN102961647A (en) Traditional Chinese medicine for treating osteoporosis
CN103751625B (en) A kind of Chinese medicine composition and application thereof for the treatment of epistaxis and hematemesis during menstruation
CN103768484A (en) Traditional Chinese prescription capable of treating gastritis
CN103341111B (en) Traditional Chinese medicine composition for treating spermatorrhea
CN105943597A (en) Traditional Chinese medicine composition capable of enhancing immunity and preventing and treating radiation diseases
CN102258626A (en) Traditional Chinese medicine compound Tenghuanglin, preparation method and application thereof
CN105902607A (en) Fiveleaf gynostemma herb-containing traditional Chinese medicine composition
CN105641128A (en) Traditional Chinese medicine composition for treating herpes zoster
CN105213972A (en) A kind of pharmaceutical preparation of promoting blood circulation to remove obstruction in the collateral and application thereof
CN111150816A (en) Traditional Chinese medicine composition, compound preparation, preparation method and application of preparation
CN104383097A (en) Traditional Chinese medicine for treating lupus erythematosus
CN1931268B (en) Acne treating medicine
CN104043085A (en) Traditional Chinese medicine for treating vomitus gravidarum

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160831

WD01 Invention patent application deemed withdrawn after publication